FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine. What is described is a system of the transdermal delivery of a drug containing an effective dose of an antithrombotic agent, such as tirofiban, or its pharmaceutically acceptable salt. A dose of the delivered drug is proportional to an applied plaster size and reaches 60-85% of thrombocyte inhibition. The system enables providing the individualised treatment of patients. There are presented methods of treating various disorders, when the thrombocyte inhibition is required.
EFFECT: transdermal delivery system can deliver the drug to the patient for the prolonged period of time.
25 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITHROMBOTIC PREPARATION AND METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS | 2002 |
|
RU2205027C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
| ANTITHROMBOTIC COMPOUND | 2012 |
|
RU2604733C2 |
| TRANSDERMAL COMPOSITION FOR LOCAL ADMINISTRATION OF THERAPEUTIC AND/OR PROPHYLACTIC ACTIVE AGENT, BAND OR BANDAGE FOR TRANSDERMAL DELIVERY | 1992 |
|
RU2117490C1 |
| TRANSDERMAL PLASTER | 2011 |
|
RU2553350C2 |
| METHOD FOR PREVENTION OF SYSTEMIC PULMONARY BYPASS THROMBOSIS | 2018 |
|
RU2782074C2 |
| DEVICE HAVING COATED MICRO PROJECTIONS FOR CARRYING OUT TRANSDERMAL DRUG DELIVERY | 2001 |
|
RU2282468C2 |
| NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN | 2001 |
|
RU2302880C2 |
| METHOD FOR INHIBITING REDUCTION OF TRANSDERMAL DRUG MOVEMENT BY INHIBITING PATHS CLOSING | 2001 |
|
RU2272618C2 |
| METHOD OF AMELIORATING CLOTTING PATHOLOGIES AND RELATED MATERIALS AND METHODS | 2013 |
|
RU2613167C2 |
